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Edited by Aleksander BenjakAbstract RBF-2 is a factor comprised of a USF1/2 heterodi-
mer, whose association with a highly conserved upstream element
(RBEIII) on the HIV-1 LTR requires a co-factor TFII-I. We
have identiﬁed speciﬁc nucleotides, immediately 3 0 of RBEIII
that are required for stable association of TFII-I with this region
of the LTR. Mutations that inhibit interaction of TFII-I with
DNA also prevent stimulation of USF binding to RBEIII, and
render the integrated LTR unresponsive to T cell signaling.
These results demonstrate an essential role of TFII-I bound at
an upstream LTR element for viral replication.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Transcription from the HIV-1 long terminal repeat (LTR) is
tightly linked to T-cell activation through the function of fac-
tors responsive to signaling by the T-cell receptor and cyto-
kines, including NF-jB, NFAT, GABP/Ets and API bound
to the LTR enhancer region (reviewed in Ref. [1]) (see
Fig. 1A). Additionally, we have previously shown that RBF-
2, comprised of USF1, USF2 and TFII-I, bound to a highly
conserved upstream element (RBEIII, Fig. 1A) is essential
for induction of the LTR in response to MAPK signaling in
T cells [2,3]. RBEIII is an atypical binding site for USF, but
is as highly conserved on LTRs from patients as are the TATA
box and NFAT/NF-jB enhancer elements ([2,4] and see Table
1). In contrast, the prototypical HIV-1 LTR bears a strong
consensus E box element for USF further upstream that is less
well conserved (Fig. 1A and Table 1). USF binds to RBEIII
with several hundredfold less aﬃnity than a consensus E box
in vitro, but this interaction is strongly stimulated by addition
of TFII-I, without formation of a stable ternary complex [2].
Mutation of the core RBEIII element prevents induction of
the integrated LTR by a-CD3 TCR crosslinking, and co-treat-
ment with PMA and ionomcycin, which activate the Ras-
MAPK and calcinuerin-NFAT pathways, respectively [2,3].
Furthermore, integrated LTRs with mutations in RBEIII con-
sistently display elevated basal transcription relative to wild-
type [2], and concomitantly have reduced levels of associated
HDAC3 [3]. We have proposed that USF 1/2 and TFII-I
bound at RBEIII are involved in repression of the latent pro-*Corresponding author. Fax: +1 604 822 5227.
E-mail address: sadowski@interchange.ubc.ca (I. Sadowski).
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for enabling induction of the LTR in response to MAPK sig-
naling, perhaps by maintaining organization of the LTR in a
conformation amenable to activation by MAPK-responsive
transcription factors bound to the enhancer region [1].
Although we have observed TFII-I from Jurkat nuclear ex-
tracts bound to RBEIII-containing oligonucleotides in EMSA
[3], and have shown that TFII-I co-puriﬁes with USF1 and
USF2 using RBEIII element-speciﬁc aﬃnity chromatography
[5], a speciﬁc interaction between TFII-I and upstream se-
quences on the HIV-1 LTR has not been identiﬁed. In this re-
port, we deﬁne nucleotides required for direct interaction of
TFII-I with this region of the LTR, immediately 3 0 ﬂanking
the RBEIII core USF1/2 binding site, and show that this spe-
ciﬁc interaction is necessary for induction of latent provirus.2. Materials and methods
2.1. Recombinant DNA molecules
Oligonucleotides for construction of plasmids, mutagenesis, DNasel
footprinting and Chromatin Immunoprecipitation are detailed in Sup-
plementary Table 1. The pTYeGFP-WT reporter virus construct was
produced by replacing the enhancer-less 3 0 LTR in pTYeGFP [6] (ob-
tained from the NIH-AIDS Reagent Program) with an LTR fragment
ampliﬁed from pLAI using primers oTM237 and oTM238 containing
unique EcoRI and Kpnl restriction sites. LTR mutations were created
by site directed mutagenesis in pTM3235, which is pBluescript contain-
ing the wild-type EcoRI/Kpnl LAI LTR fragment.2.2. Cell culture and viral replication assays
Lymphoblastoid Jurkat T-cells, and Jurkat-Tat T-cells were ob-
tained from the NIH AIDS Reagent Program. Human Kidney 293T,
and Sf21 insect cells were obtained from the American Type Culture
Collection (ATCC). Jurkat T-cells were grown in 1640 RPMI + 10%
Fetal Bovine Serum (FBS) supplemented with penicillin (100 U/ml)
and streptomycin (100 mg/ml), and maintained at 37 C in a 5% CO2
atmosphere. The Jurkat-Tat, and derivative lines with integrated re-
porter virus, were maintained under the same conditions, except that
400 lg/ml G-418 was added to the media. Human kidney 293T cells
were grown in Dulbeccos Modiﬁed Eagle Medium (DMEM) + 10%
FBS (Gibco-BRL) supplemented with penicillin (100 U/ml) and strep-
tomycin (100 mg/ml), and maintained at 37 C with a 5% CO2 atmo-
sphere. Sf21 insect cells were grown in TC-100 insect media + 10%
FBS (Gibco-BRL) and maintained at 27 C.
The pTYeGFP-LTR reporter viruses were produced by co-transfec-
tion of 293T cells with Gag/Pol, Rev, Tat, and VSV-G expression plas-
mids as described [6]. Infected Jurkat-Tat cells were monitored for
eGFP expression 24 h post-transfection and sorted into 96 well plates
for isolation of individual clones. Cells with integrated reporter virus
were cultured in 75 cm2 culture ﬂasks to a cell density of 2.0 · 105/
ml prior to induction with PMA (25 ng/ml) and ionomycin (l mM)
for 24 h.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Panel A. Schematic representation of the chromosomally
integrated HIV-1 LTR, indicating positions of binding sites for USF1/
2, GABP, NFAT/NF-jB, Spl, TFII-I and LSF/YY1. Panel B.
Sequences of oligonucleotides used as competitors in panels C and
D. The RBEIII core is boxed and the location of a sequence resembling
an Inr [14] underlined. Nucleotide substitutions are indicated in lower
case. Panels C and D. EMSA was performed with recombinant TFII-I
and the RBEIII wt oligonucleotide probe (Panel B). Unlabeled
competitor oligos, as indicated above, were added in 100-fold molar
excess.
Table 1
Conservation of elements on the HIV-1 LTR.
Factor Consensus Locationa Frequencyb
TBP TATAA 28 81
Spl GGGCGG 55, 65, 79 74
NFjB GGGACTTTCC 90, 104 99
USF/RBEIII ACTGCTGA 129 93
TFII-I CTGACATC 125 99.5
USF CACGTG 166 30
aLocation of the element(s) relative to the transcriptional start.
bProportion (%) of full HIV-1 subtype B genome sequences in the HIV
sequence database with an exact match to the indicated consensus
sequence.
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USF1, USF2 and TFII-I were produced in Sf21 insect cells using
baculovirus [2]. Jurkat nuclear extracts were prepared as described pre-
viously [7]. Oligonucleotide probes for use in EMSA (Supplementary
Table 2) were labeled by end ﬁlling reactions with Klenow and unin-
corporated label was removed using Sephadex G-50 spin columns
(Pharmacia) [2]. EMSA binding reactions were performed as previ-
ously described [2,3], and resolved on non-denaturing polyacrylamide
gels for 5 h at 20 V/cm. Footprinting templates were produced from
wild-type or mutant LAI LTRs by ampliﬁcation using primers
oTM122 and oTM123. The fragments were digested with AscI and la-
beled by end ﬁlling with Klenow. Unincorporated label was removed,
and the probes digested with Xbal and gel puriﬁed to minimize signalfrom non-speciﬁc end-labeling. DNasel footprinting reactions were
performed as previously described [8] Chromatin immunopreciptation
assays with USF1, USF2 and TFII-I antibodies were as in previous
experiments [2,3].3. Results
3.1. Nucleotides immediately 3 0 of the RBEIII are required for
interaction with TFII-I
TFII-I was initially identiﬁed as a protein bound to the
AdML initiator element (Inr) [9], and was subsequently ob-
served bound to various upstream promoter sequences in asso-
ciation with additional factors [10–13]. However, there is some
controversy as to whether TFII-I recognizes a speciﬁc sequence
consensus [9,14], and it was even suggested that TFII-I family
members might be capable of binding diﬀerent speciﬁc se-
quences through the multiple I-repeats [15]. We found that re-
combinant TFII-I was able to form a complex on its own with
an RBEIII-containing oligonucleotide in EMSA (Fig. 1C and
lane 1), and this interaction was strongly competed by excess
unlabeled WT RBEIII oligo (lane 2) and oligos bearing the
AdML Inr (lane 3) or TSSC Inr elements [16] (lane 10). Oligo-
nucleotides bearing the c-Fos serum response element (SRE)
and serum inducible element (SIE), previously shown to bind
TFII-I [12], also competed with the RBEIII oligonucleotide,
although somewhat less eﬃciently (Fig. 1C, lanes 8 and 9).
These results indicate that interaction of TFII-I near RBEIII
may involve a DNA binding function for which a consensus
has been proposed [9,14]. In examining this region of the
LTR we noticed that 11 of 13 nucleotides overlapping the 5 0
end of the RBEIII core (underlined in Fig. 1B) matches the
Inr consensus (YYYYWCAANKKSY) bound by TFII-I on
the rat XDH/XO promoter as proposed by Clark et al. [14].
Surprisingly however, an RBEIII-containing oligonucleotide
with a 3 0 deletion (RBEIII3 0D) did not eﬃciently compete
for binding of TFII-I to the wild-type RBEIII probe
(Fig. 1C, lane 7). In contrast, an RBEIII oligo with a deletion
of the 5 0 end (RBEIII5 0D) was able to compete for binding of
TFII-I, almost as eﬀectively as the c-fos SIE and SRE oligos
(Fig. 1C, lane 6). Based on these results, we conclude that
TFII-I must primarily interact with residues 3 0 of the RBEIII
core sequence, rather than with the 5 0 ﬂanking sequences that
resemble an Inr consensus. To identify speciﬁc nucleotides re-
quired for binding TFII-I, we performed competitions with a
series of mutants of the full RBEIII oligo (Fig. 1D, and not
shown). Mutation of the four residues immediately ﬂanking
the RBEIII core (mut-G, CATC to gtag, Fig. 1B) completely
prevented competition for binding TFII-I (Fig. 1D, lane 4).
Of these four residues, substitution of the T residue to A on
its own (mut-M, Fig. 1B) noticeably inhibited competition
for binding to the wild-type oligo (Fig. 1D, lane 7), which sup-
ports the view that TFII-I interacts 3 0 of the RBEIII core
sequence.3.2. Nucleotides required for binding of TFII-I are stringently
conserved in patients
In our previous analysis, we found that the ACTGCTGA
core RBEIII sequence to be as stringently conserved on LTRs
ampliﬁed from patients [4], and on LTR sequences in Genbank
[2], as are the core promoter and enhancer elements. We exam-
ined whether nucleotides ﬂanking the RBEIII core are simi-
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Fig. 2. Speciﬁc interaction of TFII-I is required for stimulation of USF binding to RBEIII Panel A. DNasel footprinting reactions were performed
with a wild-type LAI HIV-1 LTR fragment, labeled at the 5 0 end of the bottom strand. Reactions contained template alone (lane 2), or 100 pmol
USF1 (lane 3), USF2 (lane 4), or USF1/USF2 heterodimers (lanes 5–8) produced by expression in insect cells. TFII-I was added to the reactions at
25 pmol (lane 6), 50 pmol (lane 7), or 100 pmol (lanes 8 and 9). An extract containing the yeast transcription factor Tecl was added to the
reaction in lane 10. The location of the RBEIII and the E-box motifs were determined by the Maxim and Gilbert G + A chemical cleavage pattern of
the naked template (lane 1). DNasel hypersensitive nucleotides produced by addition of USF are indicated (arrows). Panels B and C. Footprinting
reactions were performed with the LAI P3M mutant LTR (Panel B) or mut-M LTR fragment (Panel C). Reactions contained template alone (lanes
6), or 100 pmol USF1/USF2 heterodimers (lanes 2–4). TFII-I was added to the reactions at 50 pmol (lanes 3), or 100 pmol (lanes 4 and 5).
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genomic clone sequences in the NIH HIV sequence database
(http://www.hiv.lanl.gov/). Comparable to the previous analy-
sis, the RBEIII core element was conserved in 93% of these se-
quences, and interestingly, the four nucleotides immediately
ﬂanking the core, shown above to be required for binding of
TFII-I, were conserved in 99.5% of the isolates (Table 1).
Thus, the RBEIII core and immediate 3 0 ﬂanking nucleotides
are amongst the most stringently conserved cis-elements of
the viral promoter.
3.3. Speciﬁc interaction of TFII-I is necessary for binding of
USF to RBEIII in vitro
USF binds with high aﬃnity to Ebox consensus elements
(CANNTG), and accordingly addition of recombinant USF
on its own to footprinting reactions with the prototypical
wild-type LTR causes protection of the upstream Ebox ele-
ment at 160 (Fig. 2A, lanes 3–5). Consistent with previous
experiments using EMSA [2], addition of TFII-I to binding
reactions with USF causes additional protection of sequences
centered over the RBEIII core element (ACTGCTGA) (lanes
6–8). In contrast, TFII-I added on its own does not cause pro-
tection of speciﬁc sequences (Fig. 2A, compare lane 9 with
lanes 2 and 10). Thus, although speciﬁc nucleotides are re-
quired for stable interaction of TFII-I with the RBEIII oligo
in EMSA, we have not identiﬁed conditions where protection
of this region can be observed by footprinting. This character-
istic of TFII-I has been described previously for binding to the
Adenovirus major late (AdML) initiator elements [9]. We also
note that binding of USF to the upstream Ebox and RBEIII
elements causes the appearance of ﬂanking DNasel hypersen-sitivity (indicated with arrows), perhaps indicating formation
of a bend. Mutation of the RBEIII core element (P3M), previ-
ously shown to prevent binding of RBF2 (USF/TFII-I) in
EMSA [2], also prevents interaction of USF with the RBEIII
element in footprinting reactions containing both USF and
TFII-I (Fig. 2B). Furthermore, the single T–A substitution 3 0
ﬂanking the RBEIII core (mut-M), shown above to weaken
binding of TFII-I in EMSA, prevents stimulation of USF
binding to RBEIII by TFII-I (Fig. 2C, lanes 3 and 4). Reac-
tions with the mut-M template containing both TFII-I and
USF do produce some DNAsel hypersensitivity immediately
upstream of the RBEIII core, which might be caused by weak
association of USF in these reactions (indicated with arrow).
These experiments suggest that stable association of TFII-I
immediately 3 0 of the RBEIII core is required for its ability
to stimulate binding of USF to RBEIII in vitro.
3.4. TFII-I bound to the RBEIII is necessary for induction of the
integrated LTR
To examine the eﬀect of mutations that prevent binding of
TFII-I and USF to the RBEIII site on expression from the
LTR in vivo, we used a replication-defective reporter virus
(Fig. 3A). VSV-G pseudotyped wild-type and 3 0LTR mutant
virus was used to infect Jurkat-TAT cells, and integrants were
obtained by sorting for expression of an internal eGFP repor-
ter. Approximately equivalent proportions of GFP expressing
cells were produced by infections with the wild-type LAI,
P3M, and mut-M virus as determined by ﬂow cytometry
(Fig. 3B) indicating that the LTR mutants likely do not ad-
versely aﬀect viral integration. Individual clones of eGFP
expressing cells were isolated by FACS and expanded for
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Fig. 3. Reporter virus for assaying eﬀect of LTR mutations on
replication. Panel A. The self-inactivating 3 0 LTR in pTYeGFP was
replaced with wild-type, P3M and mut-M LAI LTRs. Following
infection with packaged virus, reverse transcription and integration
produces integrated reporter virus with 5 0 LTR mutations. Integrants
can be detected by expression of eGFP from the internal ElF-a
promoter. Panel B. Jurkat-TAT cells were infected with virus produced
from pTYeGFP (i, U3RD), pTYeGFP bearing the wild-type (ii, U3R
WT), mut-M mutant (iii, U3R mut-M), or P3M mutant LTR (iv, U3R
P3M). Flow cytometry to detect eGFP expression was performed 24 h
post-infection.
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reporter virus typically induced p24gag expression 4–8-fold in
response to treatment with PMA/Ionomycin (Fig. 4A). In
contrast, clones derived from infection with the P3M or mut-
M LTR mutant virus were unresponsive to treatment with
PMA/ionomycin (Fig. 4C and D). Additionally, it is evident
that both of the mutant LTRs cause an approximately 2-fold
higher basal level of p24gag expression relative to the wild-type
virus. These observations are consistent with the view that
TFII-I and USF bound at RBEIII are essential for induction
of latent viral expression in response to T-cell signals. Further-
more, the ﬁnding that mutant LTRs generally produce a high-
er basal signal than wild-type in unstimulated cells is consistent
with previous observations using LTR reporter genes inte-
grated by transfection, where we consistently observed ele-
vated basal expression caused by the P3M LTR mutation [2].
3.5. The mut-M mutation prevents interaction of USF and
TFII-I with the LTR in vivo
In previous experiments with integrated LTR reporter genes,
we have shown that USF1, USF2 and TFII-I are bound to theupstream region of the LTR in unstimulated cells, and remain
associated following stimulation with PMA/ionomycin, and
also that the P3M RBEIII mutation prevents interaction of
these factors [2]. We observe a similar result with the reporter
virus, where all three proteins can be detected on the wild-type
LTR by ChIP in both unstimulated and stimulated cells
(Fig. 5, WT LTR). In contrast, the mut-M mutation, shown
above to prevent binding of TFII-I in vitro and induction of
LTR expression, also prevents association of USF 1, USF2
and TFII-I with the upstream LTR region in vivo (Fig. 5,
mut-M LTR).
4. Discussion
The RBEIII core element and sequences immediately 3 0
ﬂanking, shown here to be required for stable association of
TFII-I in vitro, are amongst the most highly conserved cis-ele-
ments on the HIV-1 LTR in patients with AIDS (Table 1).
Mutations that prevent binding of TFII-I to this region,
including a single nucleotide point substitution, inhibits its
ability to stimulate binding of USF to RBEIII in vitro, and
also blocks induction of integrated HIV-1 reporter virus by
PMA/ionomycin. Additionally, mutations that prevent bind-
ing of USF and TFII-I to their upstream sites at RBEIII
invariably cause elevated basal expression of integrated provi-
rus [2]. These observations indicate that the combination of
TFII-I and USF bound at this upstream location are necessary
for induction of transcription in response to T-cell signaling,
but also may contribute to repression in unstimulated cells.
The upstream E-box binding site for USF at 160 on the
prototypical LAI LTR is not well conserved on sequences
from patients with AIDS (Table 1). In this respect, it is inter-
esting that the highly conserved RBEIII site lies only 40 nucle-
otides further downstream from a non-canonical E-box
binding site for USF 1/2. The additional stringent conservation
of the immediate 3 0 ﬂanking sequences implies that the speciﬁc
combination of TFII-I and USF bound at this upstream loca-
tion is critical for the viral replication cycle. USF and TFII-I
are likely also bound to RBEI [7], located immediately ﬂanking
the core promoter, as though positioned like bookends to the
enhancer and core promoter region (Fig. 1). Latent provirus is
known to have nucleosomes positioned immediately upstream
of 160 and downstream of the initiator, and it is possible that
USF/TFII-I contribute to positioning and modiﬁcation of
these histones. Alternatively, or additionally, considering the
requirement of MAP kinase signaling for induction of the inte-
grated LTR [3], binding of TFII-I to its speciﬁc upstream site
might be required to ‘‘deliver’’ activated MAP kinases for reg-
ulation of factors bound to the adjacent enhancer [17]. TFII-I
interacts with multiple diﬀerent sequence speciﬁc DNA bind-
ing factors, including in addition to USF, Myc, Phoxl, SRF,
STAT1 and STAT3 (reviewed in [1]). The results presented
here demonstrate that the USF–TFII-I interaction produces
a unique speciﬁcity, and consequently it is possible that
TFII-I may also promote binding of these additional factors
to non-canonical cis-elements. This may represent an addi-
tional largely unrecognized function for TFII-I.
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Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2008.
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